NDAINTRAVENOUSSOLUTION
Approved
Feb 2012
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
6
Clinical Trials (5)
Evaluation of Safety and Efficacy of Sodium Thiosulfate (BYON5667) Eye Drops to Reduce Ocular Toxicity in Cancer Patients Treated With SYD985
Started Jan 2022
Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors
Started Jul 2009
17 enrolled
Central Nervous System Embryonal NeoplasmEmbryonal Tumor With Multilayered Rosettes, C19MC-AlteredGerm Cell Tumor+7 more
Sodium Thiosulfate Treatment of Vascular Calcification in ESRD
Started Dec 2007
48 enrolled
Complication of HemodialysisCardiovascular Diseases
Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors
Started Sep 2005
33 enrolled
Anaplastic OligoastrocytomaAnaplastic OligodendrogliomaMixed Glioma+1 more
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors
Started Dec 2004
2 enrolled
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
Loss of Exclusivity
LOE Date
Mar 29, 2031
61 months away
Patent Expiry
Mar 29, 2031